Chen H M, Considine K B, Liao W S
Department of Biochemistry and Molecular Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
J Biol Chem. 1991 Feb 15;266(5):2946-52.
The serum concentration of rat T1 kininogen increases 20-30-fold in response to acute inflammation, an induced hepatic synthesis regulated primarily at the transcriptional level. To analyze the cis-regulatory elements responsible for the induced transcription, we fused a 1.6-kilobase segment of the rat T1 kininogen promoter to a reporter gene, chloramphenicol acetyltransferase (CAT). The resultant chimeric DNA was transfected into cultured cells. In transient transfection assays, this 5'-flanking sequence was sufficient to confer cell-specific expression: CAT activity was readily detectable when the construct was transfected into liver-derived cells, but it was not detectable in nonliver cells. Furthermore, when liver cells (Hep3B) transfected with this construct were treated with conditioned medium prepared from activated mixed lymphocyte cultures or with recombinant interleukin-6 (IL-6), a 5-fold increase in CAT activity was detected. Addition of dexamethasone to the conditioned medium or to IL-6 showed synergistic effects and resulted in a 10-fold increase in CAT activity. In contrast, when IL-1 was used with IL-6, induction of CAT activity was inhibited. Deletion analyses revealed two regions important for tissue-specific and induced regulation of T1 kininogen: sequences proximal to base pair -73 conferred enhanced expression in liver-derived cells and a distal region that conferred responsiveness to conditioned medium, recombinant IL-6, and dexamethasone. This responsive element had properties of an inducible transcriptional enhancer, and it was functional in both liver and nonliver cells when placed immediately upstream of a thymidine kinase promoter.
大鼠T1激肽原的血清浓度在急性炎症反应时会增加20 - 30倍,这是一种主要在转录水平调控的肝脏诱导合成。为了分析负责诱导转录的顺式调控元件,我们将大鼠T1激肽原启动子的1.6千碱基片段与报告基因氯霉素乙酰转移酶(CAT)融合。将所得的嵌合DNA转染到培养细胞中。在瞬时转染实验中,这个5'侧翼序列足以赋予细胞特异性表达:当构建体转染到肝脏来源的细胞中时,很容易检测到CAT活性,但在非肝脏细胞中则检测不到。此外,当用活化的混合淋巴细胞培养物制备的条件培养基或重组白细胞介素-6(IL-6)处理转染了该构建体的肝细胞(Hep3B)时,检测到CAT活性增加了5倍。向条件培养基或IL-6中添加地塞米松显示出协同作用,并导致CAT活性增加了10倍。相反,当IL-1与IL-6一起使用时,CAT活性的诱导受到抑制。缺失分析揭示了对T1激肽原的组织特异性和诱导调控很重要的两个区域:碱基对-73附近的序列赋予肝脏来源细胞中增强的表达,以及一个赋予对条件培养基、重组IL-6和地塞米松反应性的远端区域。这个反应元件具有诱导型转录增强子的特性,当置于胸苷激酶启动子上游时,它在肝脏和非肝脏细胞中均具有功能。